TELA Bio, Inc. Operating Cash Flow
TELA Bio, Inc. (TELA) reported Operating Cash Flow of -$20.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- TELA Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.38M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.17M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.87M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.72M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$28.22M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$41.59M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$40.86M.
- TELA Bio, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$40.75M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$20.55M 10-Q · filed 2026-08-11 | -$25.42M derived: sum of 3 quarters · filed 2026-08-11 | -$31.14M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$11.17M 10-Q · filed 2026-05-13 | -$16.04M derived: sum of 2 quarters · filed 2026-05-13 | -$21.76M derived: sum of 3 quarters · filed 2026-05-13 | -$29.66M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$10.59M derived: sum of 2 quarters · filed 2026-03-25 | -$18.49M derived: sum of 3 quarters · filed 2026-08-11 | -$28.22M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$13.62M derived: sum of 2 quarters · filed 2026-08-11 | -$23.35M 10-Q · filed 2025-11-14 | -$30.88M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$7.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$17.63M 10-Q · filed 2026-08-11 | -$25.16M derived: sum of 3 quarters · filed 2026-08-11 | -$34.14M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$9.72M 10-Q · filed 2026-05-13 | -$17.26M derived: sum of 2 quarters · filed 2026-05-13 | -$26.24M derived: sum of 3 quarters · filed 2026-05-13 | -$36.94M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$16.51M derived: sum of 2 quarters · filed 2026-03-25 | -$27.21M derived: sum of 3 quarters · filed 2026-03-25 | -$41.59M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$8.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$19.68M derived: sum of 2 quarters · filed 2025-11-14 | -$34.06M 10-Q · filed 2025-11-14 | -$45.12M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$10.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$25.08M 10-Q · filed 2025-08-11 | -$36.13M derived: sum of 3 quarters · filed 2026-03-25 | -$43.10M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | -$14.38M 10-Q · filed 2025-05-08 | -$25.43M derived: sum of 2 quarters · filed 2026-03-25 | -$32.40M derived: sum of 3 quarters · filed 2026-03-25 | -$43.67M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | -$11.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$18.02M derived: sum of 2 quarters · filed 2026-03-25 | -$29.28M derived: sum of 3 quarters · filed 2026-03-25 | -$40.86M 10-K · filed 2026-03-25 |
| 2023-09-30 | -$6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$18.23M derived: sum of 2 quarters · filed 2024-11-08 | -$29.81M 10-Q · filed 2024-11-08 | -$40.79M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | -$11.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$22.84M 10-Q · filed 2024-08-13 | -$33.82M derived: sum of 3 quarters · filed 2025-03-21 | -$41.47M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | -$11.57M 10-Q · filed 2024-05-10 | -$22.56M derived: sum of 2 quarters · filed 2025-03-21 | -$30.21M derived: sum of 3 quarters · filed 2025-03-21 | -$41.89M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | -$10.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$18.63M derived: sum of 2 quarters · filed 2025-03-21 | -$30.32M derived: sum of 3 quarters · filed 2025-03-21 | -$40.75M 10-K · filed 2025-03-21 |
| 2022-09-30 | -$7.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$19.34M derived: sum of 2 quarters · filed 2023-11-13 | -$29.77M 10-Q · filed 2023-11-13 | -$39.35M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | -$11.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$22.12M 10-Q · filed 2023-08-10 | -$31.70M derived: sum of 3 quarters · filed 2024-03-22 | -$38.33M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | -$10.43M 10-Q · filed 2023-05-11 | -$20.02M derived: sum of 2 quarters · filed 2024-03-22 | -$26.65M derived: sum of 3 quarters · filed 2024-03-22 | -$32.28M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | -$9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$16.22M derived: sum of 2 quarters · filed 2024-03-22 | -$21.85M derived: sum of 3 quarters · filed 2024-03-22 | -$30.43M 10-K · filed 2024-03-22 |
| 2021-09-30 | -$6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$12.26M derived: sum of 2 quarters · filed 2022-11-10 | -$20.84M 10-Q · filed 2022-11-10 | -$27.95M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | -$5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$14.21M 10-Q · filed 2022-08-11 | -$21.32M derived: sum of 3 quarters · filed 2023-03-23 | -$25.01M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | -$8.59M 10-Q · filed 2022-05-11 | -$15.69M derived: sum of 2 quarters · filed 2023-03-23 | -$19.38M derived: sum of 3 quarters · filed 2023-03-23 | -$25.73M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$10.79M derived: sum of 2 quarters · filed 2023-03-23 | -$17.15M derived: sum of 3 quarters · filed 2023-03-23 | -$24.46M 10-K · filed 2023-03-23 |
| 2020-09-30 | -$3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$10.04M derived: sum of 2 quarters · filed 2021-11-12 | -$17.35M 10-Q · filed 2021-11-12 | -$24.54M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | -$6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$13.66M 10-Q · filed 2021-08-12 | -$20.85M derived: sum of 3 quarters · filed 2022-03-23 | -$26.20M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | -$7.31M 10-Q · filed 2021-05-14 | -$14.49M derived: sum of 2 quarters · filed 2022-03-23 | -$19.85M derived: sum of 3 quarters · filed 2022-03-23 | -$25.05M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | -$7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$12.54M derived: sum of 2 quarters · filed 2022-03-23 | -$17.75M derived: sum of 3 quarters · filed 2022-03-23 | -$25.52M 10-K · filed 2022-03-23 |
| 2019-09-30 | -$5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$10.56M derived: sum of 2 quarters · filed 2020-11-12 | -$18.34M 10-Q · filed 2020-11-12 | -$24.10M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | -$5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$12.98M 10-Q · filed 2020-08-13 | -$18.75M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2019-03-31 | -$7.78M 10-Q · filed 2020-05-15 | -$13.54M derived: sum of 2 quarters · filed 2021-03-25 | ||
| 2018-12-31 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$19.92M 10-K · filed 2021-03-25 | ||
| 2018-09-30 | -$14.16M 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | -$16.37M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |